EconomyOttawa backs B.C. biotech company as US tariffs hit sector hard

Science-related industries have been hit hard by US tariffs. New federal funding is helping British Columbia expand the infrastructure and scientific capacity needed to develop Canadian-patented products, with one biotech company at the centre of the effort.